晶丰明源(688368) - 2025 Q3 - 季度财报
BPSemiBPSemi(SH:688368)2025-10-29 13:10

Financial Performance - The company achieved operating revenue of CNY 385.62 million in Q3 2025, a year-on-year increase of 9.14%[3] - The net profit attributable to shareholders reached CNY 75.68 million, up 131.81% year-on-year, with a significant increase of CNY 31.36 million compared to the previous year[4] - For the year-to-date period, the company reported total operating revenue of CNY 1.12 billion, reflecting a 2.67% increase year-on-year[5] - The company achieved a turnaround from loss to profit compared to the same period last year, resulting in an increase in basic and diluted earnings per share[10] - The net profit attributable to shareholders of the listed company increased due to continuous optimization of product structure, leading to a rise in gross profit margin and gross profit amount[10] - The basic earnings per share for the first three quarters of 2025 were CNY 1.21, a recovery from a loss of CNY 0.04 per share in the same period of 2024[33] - Net profit for the first three quarters of 2025 was ¥27,366,932.46, compared to a net loss of ¥29,583,101.21 in 2024, marking a significant turnaround[20] Revenue and Costs - The revenue from motor control driver chips increased by 24.86%, with its proportion of total revenue rising by 4.58 percentage points year-on-year[5] - Total operating revenue for the first three quarters of 2025 reached ¥1,117,105,017.69, a 2.5% increase from ¥1,088,020,033.15 in the same period of 2024[19] - Total operating costs decreased to ¥1,110,336,254.99, down 3.1% from ¥1,145,572,718.76 year-over-year[19] - The gross profit for the first three quarters of 2025 was CNY 295.14 million, resulting in a gross margin of approximately 34.0%, compared to a gross margin of 29.5% in the first three quarters of 2024[32] Research and Development - Research and development expenses totaled CNY 104.20 million in Q3 2025, a decrease of 4.18% compared to the same period last year[4] - Research and development expenses as a percentage of operating income decreased by 3.76 percentage points, mainly due to an increase in operating income and a decrease in R&D expenses[10] - Research and development expenses for the first three quarters of 2025 were ¥278,807,668.26, slightly lower than ¥292,632,983.99 in 2024[19] - Research and development expenses increased to CNY 178.71 million in the first three quarters of 2025, up from CNY 170.26 million in the same period of 2024, reflecting a focus on innovation[32] Cash Flow and Assets - The net cash flow from operating activities for the year-to-date period was CNY 147.44 million, down 43.61% year-on-year due to timing differences in bank acceptance bills[6] - The net cash flow from operating activities decreased by 43.61% year-on-year, primarily due to timing differences in the maturity of bank acceptance bills and increased cash payments to employees[10] - The company's cash and cash equivalents were CNY 158,358,378.71, down from CNY 280,476,364.28, a decline of about 43.5%[15] - The company's cash and cash equivalents at the end of the period were ¥149,607,625.72, down from ¥274,837,703.56 at the end of 2024[25] - The ending cash and cash equivalents balance for the first three quarters of 2025 was $84.71 million, down from $155.70 million in 2024[36] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,574[12] - The top three shareholders held a combined 61.49% of the shares, with Hu Liqiang holding 24.22%, Xia Feng holding 22.18%, and Hainan Jingzhe Rui Venture Capital Partnership holding 15.09%[12] Financial Position - The company's net assets attributable to shareholders decreased by 6.90% to CNY 1.17 billion compared to the end of the previous year[5] - As of September 30, 2025, total assets amounted to CNY 1,974,022,466.79, a decrease from CNY 2,147,443,356.56 as of December 31, 2024, reflecting a decline of approximately 8.06%[15] - Total liabilities decreased to CNY 802,061,890.72 from CNY 830,341,397.88, representing a reduction of approximately 3.41%[17] - The company's equity attributable to shareholders decreased to CNY 1,171,960,576.07 from CNY 1,258,862,606.31, a decline of about 6.9%[17] Investment Activities - Investment activities resulted in a net cash outflow of ¥66,409,950.24, contrasting with a net inflow of ¥15,727,937.98 in the same period of 2024[25] - The company reported a significant investment income of CNY 128.30 million in the first three quarters of 2025, compared to CNY 14.79 million in the same period of 2024, highlighting improved investment performance[32] Other Financial Metrics - The weighted average return on net assets rose to 0.66%, an increase of 2.46 percentage points year-on-year[3] - The company received a non-recurring gain of 681,626.48 yuan from tax refund fees during the reporting period[10] - The company has not identified any significant non-recurring gains or losses that were not listed in the relevant disclosure announcements[10] - The company's financial expenses decreased to ¥6,424,458.94 from ¥9,464,351.02 in the previous year, indicating improved cost management[19]